Bionano Genomics appoints Vince Wong to its board of directors – QNT Press Release

[ad_1]

San Diego, December 22, 2021 (GLOBE NEWSWIRE) – Bionano Genomics, Inc. (BNGO), pioneer of Saphyr’s optical genome mapping (OGM) solution® Systems and a leading genomic data visualization, interpretation and reporting software solution provider, today announced the appointment of Vincent Wong, PhD, MBA, as a member of the board of directors.

Mr. Wong is currently the Chief Commercial Officer of Geneoscopy, Inc., a life science company focused on the development of diagnostic tests for gastrointestinal health. After working for Roche Diagnostics for nearly 18 years, he joined Geneoscopy in March 2021, where he held senior leadership positions in various areas of business execution, including product marketing, sales, strategy, business development, market access and communication . His team provides services to doctor groups, hospital systems, patients, biopharmaceuticals, retail pharmacies, and payers in the fields of diabetes, oncology, infectious diseases and women’s health.

“We are very pleased that Vince has joined the board of directors,” said Dr. Erik Holmlin, President and CEO of Bionano Genomics. “Vince has extensive experience in business leadership, pharmaceutical industry, market access and clinical diagnostic commercialization, which complements the outstanding experience we already have. I am very happy to work closely with Vince to help us improve our business Implement and advance efforts related to OGM market access.”

“I’m very happy to join Erik and his colleagues on the board of directors of Bionano and get deeper into the genomics industry.” Vince added: “I spend most of my time at Roche Diagnostics in the Ventana business, which is automated Outdated and cumbersome…

The full story on Benzinga.com

[ad_2]

Source link

Recommended For You

About the Author: News Center